Evidence mounts for need to study Pfizer’s Paxlovid for long COVID
© Reuters By Julie Steenhuysen CHICAGO (Reuters) – Additional reports of patients with long COVID who were helped by Pfizer Inc (NYSE:)’s oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test […]
